Kappa Free Light Chain Index in the Real World-Do We Miss Clinically Relevant Information by Skipping Oligoclonal Banding?
View abstract on PubMed
Summary
This summary is machine-generated.The kappa-free light chain (κ-FLC) index shows high agreement with oligoclonal bands (OCB) in CSF diagnostics. A reflex strategy using κ-FLC index followed by OCB testing in a gray zone is recommended.
Area Of Science
- Neurology
- Immunology
- Clinical Diagnostics
Background
- Lack of a standardized method for integrating kappa-free light chain (κ-FLC) index into routine cerebrospinal fluid (CSF) diagnostics.
- Need to establish the diagnostic utility and optimal application of the κ-FLC index in comparison to established methods.
Purpose Of The Study
- To assess the concordance between the κ-FLC index and CSF-restricted oligoclonal bands (OCB).
- To define a κ-FLC index range necessitating confirmatory OCB testing.
Main Methods
- Retrospective analysis of 632 CSF and serum samples analyzed between December 2023 and December 2024.
- κ-FLC levels measured by nephelometry; OCB detected by isoelectric focusing and immunoblotting.
- Defined positivity thresholds: ≥ 6.1 for κ-FLC index and ≥ 3 CSF-restricted bands for OCB.
Main Results
- High agreement observed between κ-FLC index and OCB results.
- A 'gray zone' for κ-FLC index (3.5-20) identified, showing discordant results in 16% of samples.
- κ-FLC index > 20 demonstrated >95% predictive value for OCB positivity.
Conclusions
- The κ-FLC index is a reliable marker in CSF diagnostics, showing strong correlation with OCB.
- A reflex diagnostic strategy, initially employing κ-FLC index and subsequently OCB testing for values in the 3.5-20 range, is proposed.
- This approach may optimize diagnostic workflows for neurological conditions.

